awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34973750-1F6016C9-ED80-4609-B038-71CC27310D74
Q34973750-1F6016C9-ED80-4609-B038-71CC27310D74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973750-1F6016C9-ED80-4609-B038-71CC27310D74
Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents
P2860
Q34973750-1F6016C9-ED80-4609-B038-71CC27310D74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973750-1F6016C9-ED80-4609-B038-71CC27310D74
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a824c796b2dbfd78ecfc3a91a09bfb8e11027052
P2860
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial.